Evidence map›Paper›PMID 42158788›Full record

ArticleCureus2026

Genetically Confirmed Localized Perianal Hailey-Hailey Disease Successfully Treated With Topical Difamilast: A Case Report.

Maho Maekawa, Kenji Yoshida, Keiji Tanese, Fumiko Ohara, Akira Ishiko

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maho MaekawaFirst Department of Dermatology, Toho University School of Medicine, Tokyo, JPN.
Kenji YoshidaFirst Department of Dermatology, Toho University School of Medicine, Tokyo, JPN.
Keiji TaneseFirst Department of Dermatology, Toho University School of Medicine, Tokyo, JPN.
Fumiko OharaFirst Department of Dermatology, Toho University School of Medicine, Tokyo, JPN.
Akira IshikoFirst Department of Dermatology, Toho University School of Medicine, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hailey-Hailey disease, also known as familial benign chronic pemphigus, is a rare autosomal dominant acantholytic dermatosis caused by abnormalities in ATP2C1. The disease typically affects intertriginous areas such as the axillae and groin, whereas localized involvement limited to the perianal region is exceptionally rare. We report the case of a 48-year-old woman who presented with pruritus and pain in the perianal region for one year. The lesion had been refractory to topical corticosteroid therapy. Physical examination revealed a brownish, thickened plaque with erosion and maceration around the anus. Histopathological examination demonstrated suprabasal clefting and acantholysis, creating a dilapidated brick wall appearance. Direct immunofluorescence staining was negative. Genetic analysis identified a donor splice-site mutation in ATP2C1 (c.899+1G>T), confirming the diagnosis of Hailey-Hailey disease. Treatment with topical difamilast, a phosphodiesterase-4 inhibitor, led to improvement of pruritus and gradual epithelialization of the erosion over two months, with no recurrence during seven months of follow-up. Localized perianal Hailey-Hailey disease is an important diagnostic consideration in chronic treatment-resistant perianal erosions. This case highlights the value of careful clinicopathological evaluation and genetic testing in atypical presentations and suggests that topical difamilast may be a useful therapeutic option for localized disease.

Indexed as

atp2c1 mutationdifamilastfamilial benign chronic pemphigushailey-hailey diseaseperianal lesionphosphodiesterase-4 inhibitor

Identifiers

PMID42158788
PMCPMC13181299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.